Scientists say the experimental drug Zorevunersen for Dravet Syndrome significantly reduced seizures in children during early clinical trials in the United Kingdom, offering hope for treating the rare, drug-resistant genetic epilepsy.
Early Trial Shows Major Seizure Reduction in ChildrenResearchers report that zorevunersen cut seizure frequency in children with ...